Loading...
Bioxyne Limited
BXN.AX•ASX
Consumer DefensivePackaged Foods
A$0.03
A$0.00(0.00%)
Bioxyne Limited (BXN.AX) Financial Performance & Statements
Review Bioxyne Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
80.70%
↑ 80.70%
Operating Income Growth
19.18%
↑ 19.18%
Net Income Growth
-586.87%
↓ 586.87%
Operating Cash Flow Growth
-323.16%
↓ 323.16%
Operating Margin
21.74%
↑ 21.74%
Gross Margin
39.67%
↑ 39.67%
Net Profit Margin
13.01%
↑ 13.01%
ROE
41.41%
↑ 41.41%
ROIC
45.75%
↑ 45.75%
Bioxyne Limited (BXN.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bioxyne Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $4.62M | $4.70M | $3.95M | $1.21M |
| Cost of Revenue | $4.01M | $3.54M | $3.38M | $738109.00 |
| Gross Profit | $607613.00 | $1.17M | $569064.00 | $470489.00 |
| Gross Profit Ratio | $0.13 | $0.25 | $0.14 | $0.39 |
| R&D Expenses | $60618.00 | $346341.00 | $3274.00 | $6548.00 |
| SG&A Expenses | $785824.00 | $1.86M | $2.64M | $449338.00 |
| Operating Expenses | $846442.00 | $2.20M | $2.64M | $604266.00 |
| Total Costs & Expenses | $4.86M | $5.74M | $6.03M | $1.34M |
| Interest Income | $0.00 | $0.00 | $2572.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$441086.00 | $54822.00 | $104202.00 | $15362.00 |
| EBITDA | -$679916.00 | -$12.38M | -$2.05M | -$65232.00 |
| EBITDA Ratio | -$0.15 | -$0.13 | -$0.44 | -$0.66 |
| Operating Income | -$238830.00 | -$1.04M | -$2.07M | -$133780.00 |
| Operating Income Ratio | -$0.05 | -$0.22 | -$0.52 | -$0.11 |
| Other Income/Expenses (Net) | -$360473.00 | -$11.34M | $170812.00 | $68544.00 |
| Income Before Tax | -$599303.00 | -$12.38M | -$1.90M | -$65228.00 |
| Income Before Tax Ratio | -$0.13 | -$2.63 | -$0.48 | -$0.05 |
| Income Tax Expense | $441086.00 | -$90687.00 | $298851.00 | -$3274.00 |
| Net Income | -$1.04M | -$12.28M | -$1.96M | $23222.00 |
| Net Income Ratio | -$0.23 | -$2.61 | -$0.50 | $0.02 |
| EPS | -$0.001 | -$0.006 | -$0.002 | -$0.001 |
| Diluted EPS | -$0.001 | -$0.006 | -$0.002 | -$0.001 |
| Weighted Avg Shares Outstanding | $2.05B | $1.90B | $1.33B | $665.65M |
| Weighted Avg Shares Outstanding (Diluted) | $2.05B | $1.90B | $1.33B | $665.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan